Alto Neuroscience, Inc.
Q2 2026 13F Holders
Symbol
ANRO
CUSIP
02157Q109
Type
Equity
Class
COM SHS
Num filings
120
Total reported value, excl. options
$778 M
Compare 2026 Q2 to
2026 Q3
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type